NewAmsterdam Pharma
NAMS
NAMS
14 hedge funds and large institutions have $362M invested in NewAmsterdam Pharma in 2022 Q4 according to their latest regulatory filings, with 14 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
14
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
1 | +$102M | |
2 | +$90.5M | |
3 | +$43.6M | |
4 |
Viking Global Investors
Stamford,
Connecticut
|
+$39.5M |
5 |
DM
Deerfield Management
New York
|
+$27M |
Top Sellers
No sellers this quarter